Sotera Health’s (SHC) Overweight Rating Reiterated at Piper Sandler

Piper Sandler reiterated their overweight rating on shares of Sotera Health (NASDAQ:SHC) in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a $22.00 target price on the stock, down from their prior target price of $24.00.

A number of other analysts have also recently issued reports on the stock. Citigroup lifted their target price on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research note on Tuesday, February 24th. Wells Fargo & Company cut shares of Sotera Health to an “overweight” rating in a research note on Thursday, January 8th. Royal Bank Of Canada began coverage on shares of Sotera Health in a research note on Thursday, January 8th. They issued an “outperform” rating and a $24.00 target price for the company. Barclays reduced their target price on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Finally, Wall Street Zen cut shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. Seven research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $20.33.

Sotera Health Price Performance

NASDAQ SHC opened at $15.78 on Wednesday. The company has a quick ratio of 2.24, a current ratio of 2.82 and a debt-to-equity ratio of 3.56. The stock has a market capitalization of $4.50 billion, a PE ratio of 38.49 and a beta of 1.82. The company has a 50 day moving average price of $14.94 and a two-hundred day moving average price of $16.48. Sotera Health has a 12-month low of $10.80 and a 12-month high of $19.85.

Sotera Health (NASDAQ:SHC) last posted its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. The firm had revenue of $280.05 million during the quarter, compared to analysts’ expectations of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The company’s revenue was up 10.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, equities analysts predict that Sotera Health will post 0.88 earnings per share for the current fiscal year.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the business’s stock in a transaction on Friday, March 6th. The shares were sold at an average price of $15.27, for a total value of $152,700,000.00. Following the completion of the sale, the director directly owned 12,735,301 shares in the company, valued at approximately $194,468,046.27. The trade was a 43.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 15.36% of the company’s stock.

Institutional Trading of Sotera Health

Institutional investors and hedge funds have recently modified their holdings of the company. IFP Advisors Inc lifted its stake in shares of Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after buying an additional 1,371 shares during the last quarter. Rothschild Investment LLC bought a new position in Sotera Health during the fourth quarter worth $27,000. Root Financial Partners LLC increased its position in Sotera Health by 217.5% during the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock worth $30,000 after acquiring an additional 1,455 shares during the period. True Wealth Design LLC increased its position in Sotera Health by 389.3% during the fourth quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock worth $32,000 after acquiring an additional 1,456 shares during the period. Finally, EverSource Wealth Advisors LLC increased its position in Sotera Health by 831.4% during the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after acquiring an additional 2,935 shares during the period. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.